Crossmark

Proton therapy versus conventional radiotherapy for the treatment of cavernous sinus benign meningioma, a randomized controlled phase III study protocol (COG-PROTON-01)

Crossref DOI link: https://doi.org/10.1186/s12885-024-13353-9

Published Online: 2024-12-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lesueur, Paul

Clarisse, Benedicte

Lequesne, Justine

Licaj, Idlir

Feuvret, Loic

Stefan, Dinu

Ricard, Damien

Noel, Georges

Balosso, Jacques

Lange, Marie

Capel, Aurelie

Durand-Zaleski, Isabelle

Castera, Marie

Legrand, Berenice

Goliot, Nicolas

Hedou, Camille

Grellard, Jean Michel

Valable, Samuel
Funding

Funding for this research was provided by:

Institut National Du Cancer (PHRC-K 20-110, INCa-DGOS_15471)
License Information

Text and Data Mining valid from 2024-12-30

Version of Record valid from 2024-12-30
More Information

Article History

Received: 2 June 2024

Accepted: 17 December 2024

First Online: 30 December 2024

Declarations

:

: This study has received ethical approval from the Comité de protection des personnes Ouest V and from National agency for medical and health products safety (Ref IDRCB 2023-A00401-44) in. All patients will give their written informed consent before any study relative assessment start.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below